KR101535835B1 - Composition for skin whitening containing corn silk extract - Google Patents
Composition for skin whitening containing corn silk extract Download PDFInfo
- Publication number
- KR101535835B1 KR101535835B1 KR1020130114515A KR20130114515A KR101535835B1 KR 101535835 B1 KR101535835 B1 KR 101535835B1 KR 1020130114515 A KR1020130114515 A KR 1020130114515A KR 20130114515 A KR20130114515 A KR 20130114515A KR 101535835 B1 KR101535835 B1 KR 101535835B1
- Authority
- KR
- South Korea
- Prior art keywords
- corn
- composition
- extract
- skin whitening
- skin
- Prior art date
Links
- 240000008042 Zea mays Species 0.000 title claims abstract description 66
- 239000000284 extract Substances 0.000 title claims abstract description 66
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 230000002087 whitening effect Effects 0.000 title claims abstract description 31
- 235000007244 Zea mays Nutrition 0.000 title description 2
- 229940089639 cornsilk Drugs 0.000 title description 2
- 239000001231 zea mays silk Substances 0.000 title description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 64
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 64
- 235000005822 corn Nutrition 0.000 claims abstract description 64
- 102000003425 Tyrosinase Human genes 0.000 claims abstract description 26
- 108060008724 Tyrosinase Proteins 0.000 claims abstract description 26
- 230000008099 melanin synthesis Effects 0.000 claims abstract description 16
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 239000002537 cosmetic Substances 0.000 claims description 16
- 235000013305 food Nutrition 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000000654 additive Substances 0.000 claims description 6
- 230000000996 additive effect Effects 0.000 claims description 5
- 230000003247 decreasing effect Effects 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 235000009508 confectionery Nutrition 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- 235000015872 dietary supplement Nutrition 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 235000013616 tea Nutrition 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 229920002261 Corn starch Polymers 0.000 claims 3
- 239000008120 corn starch Substances 0.000 claims 3
- 229940099112 cornstarch Drugs 0.000 claims 3
- 241000208340 Araliaceae Species 0.000 claims 2
- 239000000686 essence Substances 0.000 claims 1
- -1 foundation Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 235000015041 whisky Nutrition 0.000 claims 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 32
- 239000004615 ingredient Substances 0.000 abstract description 6
- 240000004668 Valerianella locusta Species 0.000 abstract description 4
- 235000003560 Valerianella locusta Nutrition 0.000 abstract description 4
- 230000003013 cytotoxicity Effects 0.000 abstract description 3
- 231100000135 cytotoxicity Toxicity 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 31
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 28
- 239000007864 aqueous solution Substances 0.000 description 19
- 229960000271 arbutin Drugs 0.000 description 14
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 8
- 244000024671 Brassica kaber Species 0.000 description 6
- 235000014750 Brassica kaber Nutrition 0.000 description 6
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 208000000069 hyperpigmentation Diseases 0.000 description 5
- 230000003810 hyperpigmentation Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 102000013760 Microphthalmia-Associated Transcription Factor Human genes 0.000 description 4
- 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 3
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 3
- 238000001378 electrochemiluminescence detection Methods 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 229960004502 levodopa Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 2
- YFTGOBNOJKXZJC-UHFFFAOYSA-N 5,6-dihydroxyindole-2-carboxylic acid Chemical compound OC1=C(O)C=C2NC(C(=O)O)=CC2=C1 YFTGOBNOJKXZJC-UHFFFAOYSA-N 0.000 description 2
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102000007665 Extracellular Signal-Regulated MAP Kinases Human genes 0.000 description 2
- 108010007457 Extracellular Signal-Regulated MAP Kinases Proteins 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- 101710093778 L-dopachrome tautomerase Proteins 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 101710173693 Short transient receptor potential channel 1 Proteins 0.000 description 2
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000000215 hyperchromic effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 150000003700 vitamin C derivatives Chemical class 0.000 description 2
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 1
- SGNZYJXNUURYCH-UHFFFAOYSA-N 5,6-dihydroxyindole Chemical compound C1=C(O)C(O)=CC2=C1NC=C2 SGNZYJXNUURYCH-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 240000001810 Angelica gigas Species 0.000 description 1
- 235000018865 Angelica gigas Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- 240000003394 Malpighia glabra Species 0.000 description 1
- 235000014837 Malpighia glabra Nutrition 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 108010051081 dopachrome isomerase Proteins 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000036564 melanin content Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 238000001422 normality test Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000010149 post-hoc-test Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 108010014402 tyrosinase-related protein-1 Proteins 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 옥수수 수염 추출물을 유효 성분으로 함유하는 피부 미백용 조성물에 관한 것이다. 본 발명의 조성물은 유효 성분으로서 옥수수 수염 추출물을 함유함으로써, 세포 독성 없이 안전하게 멜라닌 생성 세포에서의 멜라닌 생성을 억제하고, 멜라닌 생합성에 관여하는 티로시나아제의 발현을 억제하여 우수한 피부 미백 효과를 발휘할 수 있다.The present invention relates to a composition for whitening skin, which comprises an extract of corn musth as an active ingredient. The composition of the present invention can inhibit the production of melanin in melanin-producing cells safely without cytotoxicity, suppress the expression of tyrosinase involved in melanin biosynthesis, and exert an excellent skin whitening effect by containing corn salad extract as an effective ingredient have.
Description
본 발명은 옥수수 수염 추출물을 함유하는 피부 미백용 조성물에 관한 것이다.The present invention relates to a skin whitening composition containing a corn salad extract.
멜라닌은 자외선 등으로 인한 피부의 손상에 대항하여 생성되며 피부를 보호하는 작용을 한다. 멜라닌의 생합성 과정은 티로시나아제(tyrosinase)에 의한 티로신(tyrosine)의 산화로 시작되어, DOPA(3,4-디히드록시페닐알라닌)와 도파크롬(dopachrome) 등이 생성된 후 DHICA(5,6-디히드록시인돌-2-카르복실산)와 DHI(5,6-디히드록시인돌)를 거쳐 이루어지며, DHI-유멜라닌, DHICA-유멜라닌, 페오멜라닌 등이 생성되는 것으로 알려져 있다.Melanin is produced against the damage of the skin caused by ultraviolet rays and protects the skin. The process of biosynthesis of melanin begins with the oxidation of tyrosine by tyrosinase. After the production of DOPA (3,4-dihydroxyphenylalanine) and dopachrome, DHICA (5,6 -Dihydroxyindole-2-carboxylic acid) and DHI (5,6-dihydroxyindole), and it is known that DHI-eumelanin, DHICA-eumelanin, and peomelanin are produced.
구체적으로, 멜라닌 합성은 멜라노좀(melanosome) 내에 존재하는 티로시나아제 및 티로시나제 관련 단백질(tyrosinase related protein)의 작용에 의하여 이루어진다. 티로시나아제에 의하여 티로신이 산화되어 DOPA가 생성되고, 이어서 도파옥시다아제(dopaoxidase)의 작용으로 DOPA가 다시 산화되어 도파퀴논(dopaquinone)이 생성된 후, 티로시나아제 관련 단백질인 TRP-1(5,6-디히드록시인돌-2-카르복실산 옥시다아제)과 TRP-2(도파크롬 토토머라아제)의 작용에 의하여 멜라닌이 생성된다. 티로시나아제, TRP-1 및 TRP-2는 전사 인자 MITF(마이크로프탈미아-연관 전사 인자)에 의해 발현이 촉진되는데, MITF는 ERK(세포외 신호조절 키나아제)가 활성화되면 그 발현이 억제된다. 따라서 티로시나제 및/또는 MITF의 발현이 저해되거나, ERK의 발현이 촉진될 경우 미백 효과를 기대할 수 있다.Specifically, melanin synthesis is mediated by the action of tyrosinase and tyrosinase related proteins present in the melanosome. Tyrosine is oxidized by tyrosinase to form DOPA, and then DOPA is oxidized again by the action of dopaoxidase to generate dopaquinone. Then, tyrosinase-related protein TRP-1 (5, 6-dihydroxyindole-2-carboxylic acid oxidase) and TRP-2 (dopachrome tautomerase). The expression of tyrosinase, TRP-1 and TRP-2 is promoted by a transcription factor MITF (microphthalmia-associated transcription factor). MITF is inhibited when ERK (extracellular signal regulated kinase) is activated. Therefore, a whitening effect can be expected when the expression of tyrosinase and / or MITF is inhibited or the expression of ERK is promoted.
피부의 흑화는 피부 세포 내에 존재하는 멜라닌 생성세포(melanocyte)에서 생성된 멜라닌이 각질 형성 세포(keratinocyte)로 전달되어 피부 표피층에 축적되어 일어나게 된다. 피부의 멜라닌 색소 과침착은 기미, 주근깨, 검은 반점 등을 일으키는 요인이 된다. 이러한 피부의 흑화를 예방 및 개선하기 위하여 코지 산(kojic acid), 알부틴(arbutin), 비타민 C 유도체 등이 미백제로 개발되었다.Blackening of the skin occurs when melanin produced in melanocytes in skin cells is transferred to keratinocytes and accumulates in skin surface layer. Melanin pigmentation and deposition of the skin cause spots, freckles, and black spots. Kojic acid, arbutin, vitamin C derivatives and the like have been developed as a whitening agent in order to prevent and improve the blackening of such skin.
하지만, 코지 산의 경우는 시험관 내(in vitro) 티로시나아제 억제 효과에 비해 세포 상이나 생체 내(in vivo)의 멜라닌 생성 억제 효과가 미미할 뿐만 아니라, 또한 장기간 사용시 간암을 유발할 수 있다는 보고가 있었다. 또한 비타민 C 유도체 역시 화학적 안정성에 대한 문제가 있어 장기간 보관이 어렵다는 문제점이 있다.However, in the case of Koji acids in vitro (in vitro ) tyrosinase inhibitory effect compared with the cytosolic or in vivo ( in vivo of melanin synthesis inhibitory effect is not only small, but also can cause liver cancer when used for a long period of time. In addition, vitamin C derivatives have a problem of chemical stability, which makes it difficult to store them for a long period of time.
상기 언급한 바와 같이 최근 미백 활성 물질의 부작용 등이 알려짐에 따라 그 대체 원료로서 천연물 추출물을 이용한 기능성 미백 소재에 대한 연구가 활발히 진행되고 있다. 예를 들어, 한국 특허 제0864174호에는 인삼, 당귀, 감초 등이 미백 효과가 있다고 제시된 바 있고, 국내외에 특허 출원된 피부 미백 활성 식품 추출물에는 포도, 마늘, 상황버섯, 검은콩, 박, 녹두, 쌀, 쑥, 도토리, 겨, 아세로라 버찌, 콩 등이 있다. As mentioned above, it is known that side effects of whitening active materials have recently been investigated, and active whitening materials using natural extracts have been actively studied as alternative raw materials. For example, in Korean Patent No. 0864174, it has been suggested that ginseng, Angelica gigas, licorice, etc. have a whitening effect. In addition, grape, garlic, mushroom, black bean, Rice, wormwood, acorns, chestnut, acerola cherries, and beans.
지금까지 알려진 천연물 추출물을 이용한 미백 조성물은 그 효능이나 독성에 대한 확실한 검증이 충분치 못한 현실이다. 따라서 안전성 및 효과를 모두 입증할 수 있는 우수한 대체 천연 미백제의 개발이 시급한 실정이다.It is a reality that the whitening composition using natural extracts so far has not been sufficiently verified for its efficacy and toxicity. Therefore, it is urgent to develop an alternative natural whitening agent that can demonstrate both safety and efficacy.
이에 본 발명에서는 상기와 같은 개발 요구에 부응하기 위하여 예의 검토를 거듭한 결과, 옥수수 수염 추출물에 피부 미백 활성이 있음을 최초로 발견하여 본 발명에 이르게 되었다.Accordingly, the present invention has been extensively studied in order to meet the above-mentioned development needs, and as a result, it has been discovered for the first time that there is skin whitening activity in corn beard extract, leading to the present invention.
본 발명의 조성물은 유효 성분으로서 옥수수 수염 추출물을 함유함으로써, 세포 독성 없이 안전하게 멜라닌 생성 세포에서의 멜라닌 생성을 억제하고, 멜라닌 생합성에 관여하는 티로시나아제의 발현을 억제하여 우수한 피부 미백 효과를 발휘할 수 있다.The composition of the present invention can inhibit the production of melanin in melanin-producing cells safely without cytotoxicity, suppress the expression of tyrosinase involved in melanin biosynthesis, and exert an excellent skin whitening effect by containing corn salad extract as an effective ingredient have.
도 1은 마우스 유래 멜라닌 생성 세포주를 100 ppm 농도의 옥수수 수염 추출물 및 알부틴으로 3일간 처리한 후의 세포 생존율 및 멜라닌 생성량을 나타낸 그래프이다.
도 2는 1 ppm, 10 ppm 및 100 ppm 농도의 옥수수 수염 추출물 및 알부틴으로 3일간 처리한 후의 티로시나아제 발현량을 나타낸 ECL 검출 결과이다.
도 3은 1 ppm, 10 ppm 및 100 ppm 농도의 옥수수 수염 추출물 및 알부틴으로 3일간 처리한 후 생성된 도파크롬의 양을 492 nm 흡수도로 측정하여 나타낸 그래프이다.
도 4는 옥수수 수염 추출물을 4 주와 8 주간 도포한 후의 피부 밝기 변화(L* 값)를 나타낸 것이다(mean±SEM, *P<0.05). A : 옥수수 수염 추출물 0.75 % 수용액 / B : 옥수수 수염 추출물 1.5 % 수용액
도 5는 옥수수 수염 추출물을 4 주와 8 주간 도포한 후의 피부색 변화(ITA° 값)를 나타낸 것이다(mean±SEM, *P<0.05). A : 옥수수 수염 추출물 0.75 % 수용액 / B : 옥수수 수염 추출물 1.5 % 수용액
도 6은 옥수수 수염 추출물 1.5 % 수용액을 사용한 피험자의 8 주 후 피부색 이미지를 나타낸다.
도 7은 옥수수 수염 추출물을 4 주와 8 주간 도포한 후의 과색소 침착 부위의 면적 변화를 나타낸 것이다(mean±SEM, *P<0.05). A : 옥수수 수염 추출물 0.75 % 수용액 / B : 옥수수 수염 추출물 1.5 % 수용액
도 8은 옥수수 수염 추출물을 4 주와 8 주간 도포한 후의 과색소 침착 부위의 밀도 변화를 나타낸 것이다(mean±SEM, *P<0.05). A : 옥수수 수염 추출물 0.75 % 수용액 / B : 옥수수 수염 추출물 1.5 % 수용액FIG. 1 is a graph showing cell viability and melanin production after three days of treatment with a mouse-derived melanin-producing cell line at 100 ppm concentration of corn mustard extract and arbutin.
FIG. 2 shows ECL detection results showing the amount of tyrosinase expression after 3 days treatment with corn beard extract and arbutin at concentrations of 1 ppm, 10 ppm and 100 ppm.
FIG. 3 is a graph showing the amount of corn beard extract at concentrations of 1 ppm, 10 ppm and 100 ppm and the amount of dopachrome produced after 3 days of treatment with arbutin at an absorption of 492 nm.
FIG. 4 shows changes in skin brightness (L * value) after 4 weeks and 8 weeks of application of corn beard extract (mean ± SEM, * P < 0.05). A: 0.75% aqueous solution of corn mustache extract / B: 1.5% aqueous solution of corn mustard extract
FIG. 5 shows changes in skin color (ITA ° value) after 4 weeks and 8 weeks of application of corn beard extract (mean ± SEM, * P <0.05). A: 0.75% aqueous solution of corn mustache extract / B: 1.5% aqueous solution of corn mustard extract
Fig. 6 shows a color image of the subject after 8 weeks of using a 1.5% aqueous solution of corn mustache extract.
FIG. 7 shows changes in area of hyperpigmentation sites after application of corn mustache extract for 4 weeks and 8 weeks (mean ± SEM, * P < 0.05). A: 0.75% aqueous solution of corn mustache extract / B: 1.5% aqueous solution of corn mustard extract
Figure 8 shows the change in density of hyperpigmented sites after application of corn mustache extract for 4 weeks and 8 weeks (mean ± SEM, * P < 0.05). A: 0.75% aqueous solution of corn mustache extract / B: 1.5% aqueous solution of corn mustard extract
이하, 본 발명을 상세히 설명하기로 한다. 다만, 본 발명은 다양한 형태로 변경되어 구현될 수 있으며, 여기에서 설명하는 구현예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail. However, it should be understood that the present invention may be embodied in many other specific forms without departing from the spirit or essential characteristics thereof.
옥수수 수염(corn silk)이란 옥수수의 끝에 서로 엉켜 있는 가는 실로서, 대부분은 활용되지 못하고 버려지고 있다. 다만 최근 옥수수 수염의 맛과 향의 우수함이 알려져 옥수수 수염차로도 출시된 바 있고, 향료, 식품 첨가물로도 일부 사용되고 있다.A corn silk is a thread that is tangled at the end of corn, most of which is abandoned. However, recently, it has been known that the taste and flavor of corn beard is excellent, and it has also been marketed as a corn barrel, and it is also used as a spice and a food additive.
본 발명은 옥수수 수염 추출물을 유효 성분으로 함유하는 피부 미백용 조성물에 관한 것이다.The present invention relates to a composition for whitening skin, which comprises an extract of corn musth as an active ingredient.
본 발명에서 사용되는 옥수수는 그 품종에 특별히 제한은 없으나, 감미찰4호, 구슬옥, 아리찰, 흑진주찰, 얼룩찰1호, 일미찰, 찰옥4호, 다평옥, 청다옥, 평안옥, 강다옥, 장다옥, 광평옥 등이 바람직하다. 상기 옥수수 품종의 명칭은 한국 국립식량과학원 2011년 주요작물 품종해설서를 기준으로 한 것이다.The corn used in the present invention is not particularly limited to the variety of the corn, but there are no particular restrictions on the type of corn used in the present invention. However, the corn used in the present invention is not particularly limited, Dahok, Jangdahok, Gwangpyeong, and the like are preferable. The name of the corn variety is based on the description of major crop varieties in 2011 by the National Institute of Food Science and Technology.
옥수수 수염 추출물은 옥수수 수염의 전부 또는 일부를 추출하여 제조된 것일 수 있다. 옥수수 수염 추출물은 특별한 제한 없이 열수, 가온, 냉침, 교반, 초음파 방사 등의 통상의 식물 추출물 방법에 따라 추출될 수 있으며, 열수 추출 방법이 바람직하다. 또한, 물, 주정 및 유기 용매로 이루어진 군으로부터 선택되는 1 종 이상의 용매로 추출할 수 있고, 가장 바람직하게는 물, 특히 열수로 추출할 수 있다. 유기 용매는 추출용으로 사용될 수 있는 것이라면 특별히 제한되지 않는다. 일례로서, 상기 추출시 용매를 옥수수 수염 기준 정제수를 25 배 투입하여 추출할 수 있다. 상기 용매로 추출한 이후, 여과 과정을 추가로 실시할 수 있으며, 감압 농축, 동결 건조 등을 통해 분말화하여 사용할 수 있다.The corn beard extract may be prepared by extracting all or part of corn hairs. The corn musth extract can be extracted according to a conventional plant extract method such as hot water, warming, cooling, stirring, ultrasonic irradiation, and the like, and a hot water extraction method is preferable. Further, it can be extracted with at least one solvent selected from the group consisting of water, alcohol and organic solvent, and most preferably, it can be extracted with water, especially hot water. The organic solvent is not particularly limited as long as it can be used for extraction. As an example, the solvent may be extracted by adding 25 times the amount of purified corn base water. After the extraction with the solvent, a filtration process may be further performed, and the mixture may be pulverized through vacuum concentration, freeze-drying, or the like.
일 측면에서, 본 발명은 옥수수 수염 추출물을 유효 성분으로 함유하는 피부 미백용 화장료 조성물에 관한 것이다.In one aspect, the present invention relates to a cosmetic composition for skin whitening comprising corn scratch extract as an active ingredient.
본 발명의 화장료 조성물에서 옥수수 수염 추출물은 조성물 총 중량에 대하여 0.001% 내지 20%로 함유될 수 있으나, 함량은 제형 또는 화장료 조성물에 함유되는 기타 성분의 함량에 따라 적절히 조절할 수 있다. 하지만, 화장료 조성물 내 옥수수 수염 추출물의 함량이 0.001% 미만인 경우 화장료 조성물에서 실질적인 미백 효과를 기대하기 어려울 수 있으며, 20%를 초과하는 경우에는 기대 효능 대비 비경제적일 수 있다. 따라서, 조성물 총 중량에 대하여 0.001% 내지 20%로 함유되는 것이 바람직하다.In the cosmetic composition of the present invention, the extract of corn musth may be contained in an amount of 0.001% to 20% based on the total weight of the composition, but the content can be appropriately adjusted depending on the content of the other ingredients contained in the formulation or cosmetic composition. However, when the content of the extract of corn hairs in the cosmetic composition is less than 0.001%, it may be difficult to expect a substantial whitening effect in the cosmetic composition, and when it exceeds 20%, it may be uneconomical to the expected efficacy. Therefore, it is preferable that the content is in the range of 0.001% to 20% based on the total weight of the composition.
본 발명의 일 구현예에서, 본 발명의 화장료 조성물은 화장용으로 허용되는 하나 이상의 첨가제를 추가로 함유할 수 있다. 화장용으로 허용되는 하나 이상의 첨가제는 특별히 제한되지 않으며 일반 화장료에 배합되는 통상적인 성분, 예를 들어 유분, 물, 계면활성제, 보습제, 알코올, 증점제, 색소, 방부제, 향료, 킬레이트제, 부형제, 희석제, 자외선 차단제, 지방산 등일 수 있다.In one embodiment of the present invention, the cosmetic composition of the present invention may further contain at least one cosmetically acceptable additive. The at least one additive that is acceptable for cosmetics is not particularly limited and may be selected from conventional ingredients incorporated in common cosmetics such as oil, water, a surfactant, a moisturizer, an alcohol, a thickener, a colorant, an antiseptic, a flavor, a chelating agent, , Sunscreen agents, fatty acids, and the like.
본 발명의 화장료 조성물은, 특별한 제한 없이, 스킨, 로션, 크림, 젤, 에센스, 파운데이션, 화장수, 패치, 팩, 비누, 세안제 및 세정제로 이루어지는 군으로부터 선택되는 어느 하나의 제형일 수 있다.The cosmetic composition of the present invention may be any one selected from the group consisting of a skin, a lotion, a cream, a gel, an essence, a foundation, a lotion, a patch, a pack, a soap, a cleanser and a detergent without particular limitation.
본 발명의 일 구현예에서, 본 발명의 화장료 조성물은 유효 성분인 옥수수 수염 추출물 이외에, 피부 미백 효과를 상승 또는 보강시킬수 있도록 피부 미백 효과가 있다고 이미 알려졌거나 앞으로 알려질 여타의 공지된 화합물이나 식물 추출물을 함께 포함할 수 있다.In one embodiment of the present invention, the cosmetic composition of the present invention may contain other known compounds or plant extracts already known or later known to have a skin whitening effect so as to enhance or reinforce the skin whitening effect, Can be included together.
다른 측면에서, 본 발명은 옥수수 수염 추출물을 유효 성분으로 함유하는 피부 미백용 식품 조성물에 관한 것이다.In another aspect, the present invention relates to a skin whitening food composition containing corn musth extract as an active ingredient.
본 발명의 식품 조성물에서 옥수수 수염 추출물은 조성물 총 중량에 대하여 0.001% 내지 20%로 함유될 수 있으나, 함량은 식품 조성물에 함유되는 기타 성분의 함량에 따라 적절히 조절할 수 있다. 하지만, 식품 조성물 내 옥수수 수염 추출물의 함량이 0.001% 미만인 경우 식품 조성물에서 실질적인 미백 효과를 기대하기 어려울 수 있으며, 20%를 초과하는 경우에는 기대 효능 대비 비경제적일 수 있다. 따라서, 조성물 총 중량에 대하여 0.001% 내지 20%로 함유되는 것이 바람직하다.In the food composition of the present invention, the corn salad may be contained in an amount of 0.001% to 20% based on the total weight of the composition, but the content can be appropriately adjusted according to the content of other ingredients contained in the food composition. However, if the content of the corn beard extract in the food composition is less than 0.001%, it may be difficult to expect a substantial whitening effect in the food composition, and if it exceeds 20%, it may be uneconomical to the expected efficacy. Therefore, it is preferable that the content is in the range of 0.001% to 20% based on the total weight of the composition.
본 발명의 일 구현예에서, 본 발명의 식품 조성물은 식품용으로 허용되는 하나 이상의 첨가제를 추가로 함유할 수 있다. 식품용으로 허용되는 하나 이상의 첨가제는 특별히 제한되지 않으며 식품에 배합될 수 있는 통상적인 성분, 예를 들어 물, 풍미제, 향미제, 착색제, 안정화제, 방부제, 알코올, 탄산화제, 과육, 증점제, 비타민, 식물 추출물, 유기산, 미네랄, 영양제 등일 수 있다.In one embodiment of the invention, the food composition of the present invention may additionally contain one or more additives which are acceptable for food use. The at least one additive that is acceptable for foodstuffs is not particularly limited and may contain conventional ingredients that can be incorporated into foods, such as water, flavor, flavor, colorant, stabilizer, preservative, alcohol, Vitamins, plant extracts, organic acids, minerals, nutrients, and the like.
본 발명의 식품 조성물의 형태는 특별히 제한되지 않으나, 음료, 껌, 차, 과자, 비타민 복합체 및 건강 보조식품으로 이루어지는 군으로부터 선택되는 어느 하나의 형태일 수 있다.The form of the food composition of the present invention is not particularly limited, but may be any form selected from the group consisting of beverage, gum, tea, confectionery, vitamin complex and health supplement.
본 발명의 일 구현예에서, 본 발명의 식품 조성물은 주요 성분인 옥수수 수염 추출물 이외에, 피부 미백 효과를 상승 또는 보강시킬수 있도록 피부 미백 효과가 있다고 이미 알려졌거나 앞으로 알려질 여타의 공지된 화합물이나 식물 추출물을 함께 포함할 수 있다.In one embodiment of the present invention, the food composition of the present invention may contain, in addition to the main ingredient corn musth extract, other known compounds or plant extracts already known or later to have a skin whitening effect so as to enhance or reinforce the skin whitening effect Can be included together.
본 발명에서는 기존에 식품 재료로 알려진 옥수수 수염 추출물의 피부 미백 관련 활성을 측정하였다. 그 결과, 추출물임에도 불구하고 멜라닌 생성세포에서 동일 농도의 단일 물질인 알부틴 보다 높은 멜라닌 생성 억제 활성을 세포독성 없이 나타냄을 확인하였다.In the present invention, skin whitening-related activity of corn beard extract, which is known as a food material, was measured. As a result, it was confirmed that melanogenesis inhibitory activity of melanin - producing cells was higher than that of arbutin, which is a single substance at the same concentration, without cytotoxicity.
또한 옥수수 수염 추출물은 멜라닌 생성세포 내에서의 티로시나아제 발현량을 크게 감소시켰고, 이 역시 알부틴에 비하여 효과가 우수하였다.In addition, corn beard extract significantly reduced tyrosinase expression in melanin - producing cells, which was also superior to arbutin.
또한 안면에 과색소 침착이 있는 여성 피험자들에게 옥수수 수염 추출물 수용액을 도포시 모두 이상 반응 없이 유의한 피부색 완화 효과를 나타내었다.In addition, application of the aqueous solution of corn mustache extract to female subjects with hyperpigmented calcification on the face showed significant skin color reduction effect without any adverse reaction.
따라서 옥수수 수염 추출물은 티로시나아제의 발현을 억제함으로써 멜라닌 생성을 감소시키는 것으로 판단된다. 옥수수 수염 추출물은 천연 소재임에도 불구하고 최근 화장료 조성물에 가장 널리 쓰이고 있는 미백 기능성 고시물질인 알부틴을 대체할 안정한 피부 미백 소재로 사용될 수 있을 것이다.Therefore, corn mustache extract is thought to reduce melanin production by inhibiting expression of tyrosinase. The corn mustache extract may be used as a stable skin whitening material to replace arbutin, which is the most commonly used whitening functional substance, which is recently used in cosmetic compositions.
하기의 실시예를 통하여 본 발명을 보다 상세하게 설명한다. 그러나 하기 실시예는 본 발명의 내용을 구체화하기 위한 것일 뿐 실시예에 의해 본 발명이 한정되는 것은 아니다.The present invention will be described in more detail with reference to the following examples. However, the following examples are for the purpose of illustrating the present invention and are not intended to limit the scope of the present invention.
[실시예][Example]
통계 분석Statistical analysis
본 실시예에서 데이터의 통계적 유의성은 SPSS Package Program(미국 IBM사 제조)을 이용하여 분석하였다. 인체 시험시 정규성 검정은 샤피로-윌크스 검정(Shapiro-Wilks test)을 적용하였으며, 시점별 비교는 모수의 경우에는 반복측정 분산분석법(Repeated measures ANOVA), 비모수일 경우에는 윌콕슨 부호 순위 검정(Wilcoxon's signed-ranks test) 후에 사후 보정 값을 적용하였다.Statistical significance of the data in this embodiment was analyzed using SPSS Package Program (manufactured by IBM, USA). The Shapiro-Wilks test was used for the normality test in the human body test. The point-by-point comparison was conducted using the repeated measures ANOVA for the parameters and the Wilcoxon's signed -ranks test).
옥수수 수염 추출물의 제조Preparation of corn mustache extract
옥수수 수염을 흐르는 물로 세척하고, 전처리로서 135 ℃에서 1 시간 동안 가열하여 멸균하였다. 옥수수 수염 기준으로 25 배의 정제수를 투입하고 98 내지 100 ℃ 이상의 온도에서 1 시간 30 분 동안 추출하였다. 추출액을 메쉬(mesh)를 이용하여 여과한 다음 60 ℃ 이하에서 농축하여 저장하였다. 저장된 농축액을 마이크로필터를 이용하여 다시 여과한 다음 125 ℃에서 8 초 동안 가열하여 살균하였다.Corn beard was washed with running water and sterilized by heating at 135 ° C for 1 hour as a pretreatment. Twenty-five times the amount of purified water based on the corn hairs was added and the mixture was extracted at a temperature of 98 to 100 ° C or more for 1.5 hours. The extract was filtered using a mesh and concentrated at 60 ° C or lower. The stored concentrate was filtered again using a microfilter and sterilized by heating at 125 DEG C for 8 seconds.
멜라닌 생성 세포의 세포 생존율 및 멜라닌 생성량 측정Measurement of cell viability and melanin production of melanin-producing cells
옥수수 수염 추출물이 마우스 유래 멜라닌 생성 세포주에서 세포의 생존율과 멜라닌 생성량에 미치는 영향을 측정하였다. 10% FBS(소 태아 혈청)와 1% 페니실린-스테렙토마이신, 200 nM의 포르볼-12-미리스테이트 13-아세테이트가 함유된 RPMI 1640 배지를 이용하여 37 ℃, 5% CO2 조건 하에서 배양하였다. 옥수수 수염 추출물과 양성 대조 물질인 알부틴을 각각 1 ppm, 10 ppm, 100 ppm의 농도로 3 일간 처리한 후 세포 생존율과 멜라닌 함량을 측정하여 그 결과를 하기 표 1 및 표 2 에 나타내었다. 세포 생존율은 시료를 처리하지 않은 세포 대비 생존한 정도를 % 로 표시한 것이다. The effect of corn mustache extract on cell survival and melanin production in mouse - derived melanin - producing cell lines was measured. The cells were cultured in RPMI 1640 medium containing 10% FBS (fetal bovine serum) and 1% penicillin-streplomycin and 200 nM of forbol-12-myristate 13-acetate under 37 ° C and 5% CO 2 . Arbutin, which is a positive control substance, and arbutin, which is a positive control substance, were treated for 3 days at concentrations of 1 ppm, 10 ppm, and 100 ppm, respectively, and cell viability and melanin content were measured. The results are shown in Tables 1 and 2 below. The cell survival rate is expressed as a percentage of survival relative to the untreated cells.
옥수수 수염 추출물
Corn mustache extract
알부틴
Arbutin
표 1에 나타난 바와 같이, 알부틴과 옥수수 수염 추출물을 처리한 것 모두 처리한 모든 농도에서 멜라닌 생성 세포 생존율에 큰 변화가 없음을 확인하였다.As shown in Table 1, it was confirmed that there was no significant change in the melanin-producing cell survival rate at all the concentrations treated with arbutin and corn bean extract.
옥수수 수염 추출물
Corn mustache extract
알부틴
Arbutin
표 2에 나타난 바와 같이, 옥수수 수염 추출물을 처리한 것이 동일한 농도의 알부틴을 처리한 것 보다 멜라닌 생성량이 더 적음을 확인하였다.As shown in Table 2, it was confirmed that the treatment with corn beard extract had a lower amount of melanin than the treatment with the same concentration of arbutin.
비교를 용이하기 위해 100 ppm에서의 세포 생존율과 멜라닌 생성량을 동시에 도 1에 나타내었다.The cell viability at 100 ppm and the amount of melanin production are shown in FIG. 1 at the same time to facilitate comparison.
티로시나아제 발현에 미치는 영향 측정Measurement of effect on tyrosinase expression
멜라닌 생합성 과정에 주요한 역할을 하는 티로시나아제의 발현에 미치는 영향을 측정하기 위하여, 웨스턴 면역 블로팅(western immunoblotting)을 실시하였다. 옥수수 수염 추출물을 melan-a 세포에 3 일간 처리 후 분해 버퍼(lysis buffer)로 단백질을 추출하여 50 ㎍을 분석에 사용하였다. 8 % SDS-폴리아크릴아미드 겔을 사용하여 분리 후 티로시나아제 1차 항체(1/250 희석)와 항-산양(anti-goat) 2차 항체(1/13000 희석) 조건으로 ECL(증강 화학발광) 검출한 결과를 도 2에 나타내었다. 도 2에 나타낸 바와 같이, 옥수수 수염 추출물을 1 ppm, 10 ppm, 100 ppm의 농도로 3 일간 처리 한 결과, 10 ppm 이상의 농도에서 멜라닌 생합성 과정의 초기에 관여하는 티로시나아제 발현량을 알부틴보다 더 효과적으로 감소시켰음을 확인하였다. Western immunoblotting was performed to determine the effect of tyrosinase expression, which plays a major role in the melanin biosynthesis process. The corn mustache extract was treated with melan-a cells for 3 days and then extracted with lysis buffer. After separation using 8% SDS-polyacrylamide gel, ECL (enhanced chemiluminescence) was performed under conditions of tyrosinase primary antibody (1/250 dilution) and anti-goat secondary antibody (1/13000 dilution) ). The results are shown in Fig. As shown in Fig. 2, when corn musth extract was treated for 3 days at a concentration of 1 ppm, 10 ppm, and 100 ppm, the amount of tyrosinase expressed early in the melanin biosynthesis process at a concentration of 10 ppm or more was higher than that of arbutin Respectively.
티로시나아제 활성 억제 효과 측정Measurement of inhibitory effect of tyrosinase activity
옥수수 수염 추출물이 티로시나아제 활성에 미치는 영향을 측정하였다. 기질인 8.0 mM L-DOPA(67 mM 포스페이트 버퍼, pH 6.8에서 용해시킴) 120 ㎕와 메탄올 40 ㎕에 용해시킨 1 ppm, 10 ppm, 100 ppm 농도의 실험 시료를 96-웰 마이크로플레이트에 넣고 혼합하였다. 혼합 후 티로시나아제 40 ㎕를 가하고 20 분 후에 생성된 도파크롬의 양을 492 nm에서의 흡수도로 측정하였다. 측정 결과를 기초로 하기 식에 의거하여 저해도를 계산한 다음 그 결과를 도 3에 나타내었다.The effect of corn mustache extract on tyrosinase activity was measured. 120 μl of a substrate, 8.0 mM L-DOPA (dissolved in 67 mM phosphate buffer, pH 6.8), and 1 ppm, 10 ppm and 100 ppm concentrations of the test sample dissolved in 40 μl of methanol were added to a 96-well microplate and mixed . After mixing, 40 μl of tyrosinase was added, and the amount of dopachrome produced after 20 minutes was measured at the absorbance at 492 nm. Based on the measurement results, the degree of inhibition was calculated based on the following equation, and the results are shown in FIG.
* 저해도 = (대조구 OD492 - 샘플 OD492)/ 대조구 OD492* Inhibition = (control OD492 - sample OD492) / control OD492
도 3에 나타낸 바와 같이, 옥수수 수염 추출물은 100 ppm 이하에서 유의적인 티로시나아제 활성 저해도를 나타내지 못하였다. 이에 비추어 볼 때, 옥수수 수염 추출물은 티로시나아제 활성을 직접적으로 억제하는 것이 아니라, 멜라닌 생성 세포에서의 티로시나아제 발현량을 감소시킴으로써 멜라닌 생성을 억제하는 것으로 보인다.As shown in Fig. 3, the corn mustache extract did not show significant tyrosinase activity inhibition at 100 ppm or less. In view of this, the corn mustache extract does not directly inhibit tyrosinase activity, but appears to inhibit melanin production by decreasing the amount of tyrosinase expression in melanin-producing cells.
인체 피부 Human skin 과색소Scarlet 침착에 대한 완화 효과 평가 Evaluation of mitigation effects on deposition
안면에 과색소 침착이 형성되어 있는 36 세 내지 50 세(평균 42.9±3.9세)의 여성 피험자 42 명을 대상으로 실험하였다. 피험자를 두 그룹으로 나눈 후 각각 옥수수 수염 추출물 0.75 % 수용액과 1.5 % 수용액을 8 주간 1 일 2 회(아침, 저녁) 세안 후 안면 전체에 도포하였다.Forty - two female subjects aged 36 to 50 years (mean 42.9 ± 3.9 years) with hyperpigmented lesions on the face were examined. After dividing the subjects into two groups, a 0.75% aqueous solution of corn mustache extract and a 1.5% aqueous solution were applied to the entire face after cleansing twice a day (morning and evening) for 8 weeks.
피부색 평가는 사용 전, 사용 후 4 주 및 8 주 시점에서 세안 후 항온항습조건(22±2℃, 50±5 %)에서 20 분간 대기한 뒤 육안 평가, 피부색 측정, 과색소 침착 부위의 면적 및 밀도 분석을 실시하였다.Skin color evaluation was carried out at 4 and 8 weeks after use. After waiting for 20 minutes at constant temperature and humidity (22 ± 2 ℃, 50 ± 5%) after skin cleansing, visual evaluation, skin color measurement, Density analysis.
각각의 시점에서 육안 평가는 안면 측면의 과색소 침착 정도를 10 점 척도로 하여 표준 이미지를 기준으로 2 명의 시험자가 독립적으로 평가하였다. 피부색 측정은 분광광도계(일본 Minolta사 제조 CM-2500d)를 이용하여 L*값과 ITA° 값(ITA°=[Arc Tangent((L*-50)/b*)]180/3.14159)을 측정하였다. 또한 과색소 침착 부위의 면적 및 밀도 분석은 안면 촬영장치인 VISIA ver.5(미국 Canfield사 제조)를 이용하여 안면 촬영을 하여 촬영된 이미지를 이미지 분석 프로그램인 Image-pro plus(미국 MediaCybernetics사 제조)를 이용하여 측정하였다.At each time point, the visual evaluation was independently evaluated by two testers based on the standard image with the degree of hyperpigmentation of the facial aspect as a 10-point scale. The L * value and the ITA value (ITA ° = [Arc Tangent ((L * -50) / b *)] 180 / 3.14159) were measured using a spectrophotometer (CM-2500d, manufactured by Minolta Co., . In addition, the area and density of the hyperpigmented areas were measured using a facial imaging apparatus VISIA ver. 5 (Canfield, USA), and the images were imaged using Image-pro plus (manufactured by MediaCybernetics, Inc., USA) .
하기 표 3에 나타난 바와 같이, 과색소 침착 부위의 육안 평가 결과, 도포 전과 비교시 옥수수 수염 추출물 0.75 % 수용액은 8 주 후 시점에서, 옥수수 수염 추출물 1.5 % 수용액은 4 주 및 8 주 후 시점 모두에서 피부색이 개선되는 경향을 나타내었다.As shown in Table 3 below, the visual evaluation of the hyperpigmentation sites showed that in the case of the 0.75% aqueous solution of corn beard extract, the 1.5% aqueous solution of corn mustache extract was observed at 8 weeks, The skin color tended to be improved.
0.75
0.75
1.5
1.5
W 윌콕슨 부호 순위 검정 / 사후 검증(Post-Hoc test)A decrease in the mean value indicates an improvement in hyperpigmentation (▼)
W Wilcoxon sign rank test / post-hoc test
도 4 및 도 5에서 확인할 수 있는 바와 같이, 분광 측정기를 이용한 피부색 분석에서는 옥수수 수염 추출물 0.75 % 수용액 와 1.5 % 모두 L* 값과 ITA° 값이 도포 전과 비교시 도포 4 주 및 8 주 후 시점에서 유의하게 증가하였다(P<0.05).As can be seen from FIGS. 4 and 5, in the analysis of the skin color using the spectrophotometer, the values of L * value and ITA ° in the 0.75% aqueous solution and 1.5% of the corn mustard extract were compared at 4 weeks and 8 weeks after application ( P < 0.05).
또한 과색소 침착 부위의 면적 및 밀도 분석을 위하여 피험자의 피부색 이미지를 촬영하였고, 옥수수 수염 추출물 1.5 % 수용액을 사용한 피험자의 대표적인 8 주 후 피부색 이미지는 도 6에 나타내었다.In addition, a skin color image of the subject was taken for the analysis of the area and density of the hyperpigmented lesion site, and a representative color image of the subject after 8 weeks of using a 1.5% aqueous solution of corn mustache extract is shown in FIG.
이미지 분석 프로그램을 이용한 과색소 침착 부위의 면적 및 밀도를 분석하였다. 그 결과 도 7 및 도 8에 나타난 바와 같이, 옥수수 수염 추출물 0.75 % 수용액의 경우, 도포 전과 비교시 과색소 침착 부위의 면적은 도포 8주 후 시점에서, 과색소 침착 부위의 밀도는 4주 및 8주 후 시점에서 유의하게 감소되었다. 옥수수 수염 추출물 1.5 % 수용액의 경우는 과색소 침착 부위의 면적과 밀도 모두 4 주 및 8 주 후 시점에서 유의하게 감소되었음을 확인하였다.The area and density of hyperpigmentation sites were analyzed using image analysis program. As a result, as shown in FIG. 7 and FIG. 8, in the case of the 0.75% aqueous solution of corn musth extract, the area of the hyperchromic spot was 8 weeks after application and the density of the hyperchromic spot was 4 weeks and 8 And significantly decreased at the end of the week. In the 1.5% aqueous solution of corn mustache extract, both area and density of hyperpigmented sites were significantly decreased at 4 weeks and 8 weeks.
인체 피부 안전성 평가Evaluation of human skin safety
안전성 평가는 옥수수 수염 추출물 도포 4 주 및 8 주 후 시점에서 문진과 시험자의 관찰에 의해 주관적 자극감(subjective irritation)과 객관적 자극감(objective irritation)을 평가하였다. 피험자는 21 명이었다.The safety evaluation was conducted at 4 and 8 weeks after application of the corn beard extract, and subjective irritation and objective irritation were evaluated by the interviews and the tester's observation. There were 21 subjects.
그 결과, 하기 표 4에 나타난 바와 같이, 옥수수 수염 추출물 수용액 도포 8 주간 동안 모든 피험자에게서 피부 이상 반응 및 자극감은 관찰되지 않았다.As a result, as shown in Table 4 below, skin adverse reactions and irritation were not observed in all the subjects for 8 weeks after application of the aqueous solution of corn beard extract.
평가
evaluation
증상
Symptom
Corn beard extract 1.5%
주관적 자극감
Subjective irritability
객관적 자극감
Objective stimulation
Claims (12)
옥수수 수염 물추출물이 감미찰4호, 구슬옥, 아리찰, 흑진주찰, 얼룩찰1호, 일미찰, 찰옥4호, 다평옥, 청다옥, 평안옥, 강다옥, 장다옥 및 광평옥으로 이루어진 군으로부터 선택되는 1 종 이상의 옥수수의 수염 물추출물인 것을 특징으로 하는 피부 미백용 화장료 조성물.The method according to claim 1,
Corn hydrolyzate extracts were selected from the group consisting of Ginseng 4, Gushen, Ariruk, Bokjeongju, Ulluchul 1, Ilmyul, Cham 4, Dapyeong, Cheongdaok, Pyunganok, Kangdaok, Wherein the cosmetic composition is at least one selected from the group consisting of corn starch,
옥수수 수염 물추출물이 조성물 총 중량에 대하여 0.001% 내지 20%로 함유되는 것을 특징으로 하는 피부 미백용 화장료 조성물.3. The method according to claim 1 or 2,
A cosmetic composition for skin whitening characterized in that cornstarch water extract is contained in an amount of 0.001% to 20% based on the total weight of the composition.
화장용으로 허용되는 하나 이상의 첨가제를 추가로 함유하는 것을 특징으로 하는 피부 미백용 화장료 조성물.3. The method according to claim 1 or 2,
A cosmetic composition for skin whitening characterized by further comprising at least one additive which is acceptable for cosmetics.
스킨, 로션, 크림, 젤, 에센스, 파운데이션, 화장수, 패치, 팩, 비누, 세안제 및 세정제로 이루어지는 군으로부터 선택되는 어느 하나의 제형인 것을 특징으로 하는 피부 미백용 화장료 조성물.3. The method according to claim 1 or 2,
Wherein the composition is any one selected from the group consisting of skin, lotion, cream, gel, essence, foundation, lotion, patch, pack, soap, cleanser and detergent.
옥수수 수염 물추출물이 감미찰4호, 구슬옥, 아리찰, 흑진주찰, 얼룩찰1호, 일미찰, 찰옥4호, 다평옥, 청다옥, 평안옥, 강다옥, 장다옥 및 광평옥으로 이루어진 군으로부터 선택되는 1 종 이상의 옥수수의 수염 물추출물인 것을 특징으로 하는 피부 미백용 식품 조성물.8. The method of claim 7,
Corn hydrolyzate extracts were selected from the group consisting of Ginseng 4, Gushen, Ariruk, Bokjeongju, Ulluchul 1, Ilmyul, Cham 4, Dapyeong, Cheongdaok, Pyunganok, Kangdaok, ≪ / RTI > wherein the composition is a whiskey water extract of at least one kind of corn selected from the group consisting of:
옥수수 수염 물추출물이 조성물 총 중량에 대하여 0.001% 내지 20%로 함유되는 것을 특징으로 하는 피부 미백용 식품 조성물.9. The method according to claim 7 or 8,
A food composition for skin whitening characterized by containing cornstarch water extract in an amount of 0.001% to 20% based on the total weight of the composition.
식품용으로 허용되는 하나 이상의 첨가제를 추가로 함유하는 것을 특징으로 하는 피부 미백용 식품 조성물.9. The method according to claim 7 or 8,
A food composition for skin whitening characterized by further comprising at least one additive which is acceptable for food.
음료, 껌, 차, 과자, 비타민 복합체 및 건강 보조식품으로 이루어지는 군으로부터 선택되는 어느 하나의 형태인 것을 특징으로 하는 피부 미백용 식품 조성물.9. The method according to claim 7 or 8,
Wherein the composition is in any one form selected from the group consisting of beverage, gum, tea, confectionery, vitamin complex, and health supplement.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130035787 | 2013-04-02 | ||
KR1020130035787 | 2013-04-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140120245A KR20140120245A (en) | 2014-10-13 |
KR101535835B1 true KR101535835B1 (en) | 2015-07-10 |
Family
ID=51658524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130114515A KR101535835B1 (en) | 2013-04-02 | 2013-09-26 | Composition for skin whitening containing corn silk extract |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101535835B1 (en) |
WO (1) | WO2014163260A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101784160B1 (en) | 2015-08-18 | 2017-11-06 | 대한민국 | Composition for moisturizing Skin comprising Maysin or Corn-silk extract |
US10729164B2 (en) | 2015-10-26 | 2020-08-04 | Kwang-Soon SHIN | Immune-enhancing composition comprising arabinoxylan from corn or corn processing by-product |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102247965B1 (en) * | 2014-10-17 | 2021-05-04 | 주식회사 코리아나화장품 | Cosmetic Composition for Whitening of the Skin Comprising the Extract of Fermented Zea Mays Silk |
KR102176618B1 (en) * | 2018-09-20 | 2020-11-09 | 이호규 | Composition comprising extract of zea mays linne |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080004639A (en) * | 2006-07-06 | 2008-01-10 | 안기영 | Cosmetic products including pumpkin, red-bean, corn silk, green tea, caffeine that has an effect on natural anti-oxidants, sliming, a dropsical swelling, remove fat |
KR100955003B1 (en) * | 2008-06-09 | 2010-04-29 | 공수경 | Method of fabricating a functional soap using wild flowers and seaweeds |
KR20100125278A (en) * | 2008-02-01 | 2010-11-30 | 암콜 인터내셔널 코포레이션 | Improved skin brightening compositions |
KR20110040363A (en) * | 2009-10-14 | 2011-04-20 | 한국원자력연구원 | A composition for skin whitening comprising extracts or fractions of eremochloa ophiuroides as an active ingredient |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101067294B1 (en) * | 2009-03-19 | 2011-09-23 | 주식회사 사임당화장품 | A method for the preparation of high quality corn bran by extrusion and ultrahigh pressure treatments |
KR101241455B1 (en) * | 2010-09-17 | 2013-03-11 | 김길중 | Bean curd having hypotensive effect |
-
2013
- 2013-09-26 KR KR1020130114515A patent/KR101535835B1/en active IP Right Grant
- 2013-09-26 WO PCT/KR2013/008617 patent/WO2014163260A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080004639A (en) * | 2006-07-06 | 2008-01-10 | 안기영 | Cosmetic products including pumpkin, red-bean, corn silk, green tea, caffeine that has an effect on natural anti-oxidants, sliming, a dropsical swelling, remove fat |
KR20100125278A (en) * | 2008-02-01 | 2010-11-30 | 암콜 인터내셔널 코포레이션 | Improved skin brightening compositions |
KR100955003B1 (en) * | 2008-06-09 | 2010-04-29 | 공수경 | Method of fabricating a functional soap using wild flowers and seaweeds |
KR20110040363A (en) * | 2009-10-14 | 2011-04-20 | 한국원자력연구원 | A composition for skin whitening comprising extracts or fractions of eremochloa ophiuroides as an active ingredient |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101784160B1 (en) | 2015-08-18 | 2017-11-06 | 대한민국 | Composition for moisturizing Skin comprising Maysin or Corn-silk extract |
US10729164B2 (en) | 2015-10-26 | 2020-08-04 | Kwang-Soon SHIN | Immune-enhancing composition comprising arabinoxylan from corn or corn processing by-product |
Also Published As
Publication number | Publication date |
---|---|
KR20140120245A (en) | 2014-10-13 |
WO2014163260A1 (en) | 2014-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8916212B2 (en) | Skin whitening composition containing chia seed extract | |
KR101535835B1 (en) | Composition for skin whitening containing corn silk extract | |
KR101712608B1 (en) | - Composition for comprising -terpineol for moisturizing and improving skin wrinkle | |
KR20210004156A (en) | Composition for improving winkle or skin whitening comprising atriplex gmelinii extract or paederia scandens extract | |
KR20160123732A (en) | Cosmetic composition comprising the extract of cynara scolymus and brassica oleracea var. botrytis as active ingredient | |
KR101131574B1 (en) | Composition for skin whitening | |
KR101951559B1 (en) | Composition comprising Sinapinic acid or as active ingredients for anti-wrinkle, skin moisturizing, improving skin elasticity, exfoliating, inhibiting erythema or improving skin photo-aging | |
KR101787319B1 (en) | Composition comprising Cinchonine or as active ingredients for anti-wrinkle, skin moisturizing, improving skin elasticity, exfoliating, inhibiting erythema or improving skin photo-aging | |
KR101787318B1 (en) | Composition comprising Piperonal or as active ingredients for anti-wrinkle, skin moisturizing, improving skin elasticity, exfoliating, inhibiting erythema or improving skin photo-aging | |
KR101777992B1 (en) | Composition comprising Jasmone or as active ingredients for anti-wrinkle, skin moisturizing, improving skin elasticity, exfoliating, inhibiting erythema or improving skin photo-aging | |
ES2793232T3 (en) | Cosmetic compositions for skin whitening | |
JP2008247783A (en) | External preparation composition | |
KR100577982B1 (en) | Pack Composition for Whitening | |
KR101777544B1 (en) | Composition comprising Ionol or as active ingredients for anti-wrinkle, skin moisturizing, improving skin elasticity, exfoliating, inhibiting erythema or improving skin photo-aging | |
KR20150087141A (en) | Composition for improving skin | |
KR101295336B1 (en) | A Cosmetic Composition Comprising Fagopyrum Tataricum Extract And Preparing Method Thereof | |
KR101209220B1 (en) | A composition containing Lindera obtusiloba leaf extract for skin whitening and wrinkle treatment | |
KR20160020253A (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising atractylenolide I | |
KR102348149B1 (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, or skin moisturizing comprising parthenolide | |
KR101958105B1 (en) | Composition comprising Guaiyl acetate or as active ingredients for anti-wrinkle, skin moisturizing, improving skin elasticity, exfoliating, inhibiting erythema or improving skin photo-aging | |
KR101701502B1 (en) | Composition having effects of skin moisturizing, exfoliating, improving skin elasticity, inhibiting erythema, anti-wrinkle or improving skin photoaging comprising decanal or salt thereof | |
EP3318246B1 (en) | Whitening cosmetic composition comprising caragana sinica | |
CN101543525B (en) | Beauty composition containing vaccinium vitis-idaea extract and application thereof | |
KR20210004155A (en) | Composition for improving winkle or skin whitening comprising coreopsis lanceolate l. extract | |
KR101592117B1 (en) | A composition comprising the extract of Geranuium eriostemon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
X091 | Application refused [patent] | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20180104 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20190103 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20200107 Year of fee payment: 6 |